Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Areas with lower population density have not seen the same slowdown as urban areas.
Developing treatments for fatty liver disease has proved challenging, and there are currently no approved medications.
Optimal treatment for fatty liver disease may involve combining drugs with different mechanisms of action.
The best-performing combo, firsocostat and cilofexor, showed benefits despite missing the main study endpoint.
New report highlights cancer’s toll on racial and ethnic minorities and other underserved populations.
Readily available clinical parameters can identify those at greatest risk for hepatocellular carcinoma.
October is Liver Cancer Awareness Month.
Many people with fatty liver disease have obesity, diabetes and other metabolic conditions.
Any amount of alcohol can increase a person’s risk for several types of cancer, including cancers of the throat, esophagus, and liver.
Rates of liver complications were similar, but HIV-positive people had more non-liver cancers and non-liver-related deaths.
Researchers reported significant changes in liver, cardiovascular and diabetes markers.
Stivarga also improved survival in those with recurrent HCC after a liver transplant.
Nearly half of patients treated with the combination saw their tumors shrink in an early study.
NAFLD is the leading indicator of mortality among Medicare beneficiaries with hepatocellular carcinoma.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.